JAMA Highlights From ESC 2024
Update: 2024-09-02
Description
JAMA Editor in Chief Kirsten Bibbins-Domingo reviews 4 JAMA trials presented at this year’s European Society of Cardiology (ESC) Congress on antihypertensive continuation before elective surgery, potassium supplementation after cardiac surgery, pulmonary vein isolation for symptomatic atrial fibrillation, and a triple-drug combination pill for resistant hypertension in Africa.
Correction: an earlier version of this podcast contained an error in the conclusion of the TIGHT K trial summary, which has been updated.
Related Content:
- Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery
- Low-Dose Triple-Pill vs Standard-Care Protocols for Hypertension Treatment in Nigeria
- Is a Low-Dose Triple-Drug Combination Pill Protocol the Answer for Hypertension Control in Sub-Saharan Africa?
- Potassium Supplementation and Prevention of Atrial Fibrillation After Cardiac Surgery
- Pulmonary Vein Isolation vs Sham Intervention in Symptomatic Atrial Fibrillation
Comments
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
